Medically reviewed by Robert Burakoff, MDMedically reviewed by Robert Burakoff, MD Long-term problems after an infection with ...

Researchers from Salt Lake City-based University of Utah Health found that, while direct patient-to-patient transmission is rare, “there is a lot more movement of C. diff between surfaces ...

(Photo Credit: AFP/Getty Images) A fecal transplant is sometimes a more successful treatment for repeated C. diff than antibiotics. It often clears up the infection ... that used poop from two ...

Their findings increase understanding of the molecular drivers of C. diff infection and point to novel therapeutic strategies. The pathogen C. diff -- the most common cause of health care ...

The documentary features a woman named Daniell Koepke who talks about how she has found relief from irritable bowel syndrome (IBS) by performing a DIY poop transplant ... (or C.diff), a bacterium ...

C. diff infection is lethal in about 6% of cases in the United States, researchers said in background notes. The disease is highly contagious, but up to now it’s been unclear how it spreads ...

It can lead to diarrhea, abdominal pain and fever. C. diff infection is deadly in about 6% of cases in the United States, the researchers pointed out. “What I’m hoping we get from this paper ...

The effectiveness of fecal microbiota transplantation in resolving diarrhea associated with C difficile infection is influenced by donor antibiotic use and stool consistency.

RBX2660 has been granted Orphan Drug status, Fast Track status and gained Breakthrough Therapy Designation from the FDA in October 2015 for its potential to prevent recurrent C. diff. infection.

Pfizer's vaccine for Clostridium difficile (C. US biotech Vedanta Biosciences has been awarded up to $76.9 million to develop VE303 for high-risk Clostridioides difficile (C. diff.) infection by ...

Their findings, published March 25 in the journal Cell Host & Microbe, increase understanding of the molecular drivers of C. diff infection and point to novel therapeutic strategies. C.

Their findings, published March 25 in the journal Cell Host & Microbe, increase understanding of the molecular drivers of C. diff infection and point to novel therapeutic strategies. C.